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Introduction	  
“There is no such thing as a special category of science called applied science; there is 
science and its applications, which are related to one another as the fruit is related to the 
tree that has borne it.”     - Louis Pasteur 
 
Fluid mechanics is the study of flow, and it is a broad topic that includes all phases of 
matter, from liquid to gas to plasma – even comprising solids, in the cases of fluidized beds 
and granular materials such as sand.  The basic equations as defined by Navier and Stokes 
amount to a statement of conservation of momentum and mass, and yield a fantastically 
rich collection of solutions and phenomena.  Much attention in the 20th century focused on 
understanding turbulent behavior at large length and energy scales, but it turns out that 
there are equally fascinating effects to understand at small length and energy scales.  This 
field, which is called “microfluidics”, has its origins in the 1970’s and continues to the 
present day to be a rich source of ideas and discoveries, both technologically and 
scientifically, and has led to a large number of important industrial applications.  Here I 
will review the early history of the field and discuss more recent developments, with a 
focus on applications in biology and biochemistry. 
The	  Technology	  of	  Microfluidics	  
A key moment in the technological origin of microfluidics is generally considered to be the 
Stanford gas chromatograph developed by micromachining pioneer James Angell and his 
student Stephen Terry in 1979.1,2  This was a fully integrated device that included a 
column, detector, and micromechanical valve to regulate gas flow.  Terry et al were able to 
demonstrate chromatographic performance and even calculated the resolution in theoretical 
   
	  
plates.  They contemplated applications ranging from use in space missions to biological 
implants.  This pioneering work captured the imagination of researchers around the world 
and inspired much future activity in the field, but did not lead directly to commercial 
development or use.  In contrast, the development of microfluidic ink jet print heads during 
the same period3,4 led to broad commercial success and widespread use in the personal 
computer industry.  Ink jet printers were the first widely used microfluidic products and 
have in their own right inspired numerous spin-off applications, including in biochemical 
synthesis. 
Both the gas chromatograph and the ink jet printer were fabricated using silicon 
micromachining techniques, and it is important to note the relationship between new 
fabrication approaches and the development of microfluidic technologies.  Initially, such 
devices were made from silicon using techniques originally developed for the fabrication of 
electronic integrated circuits.  James Angell was the first to coin the term 
“micromachining” and his work led to the genesis of a field (also called microfabricated 
electromechanical machines, or MEMS) which created accelerometers and many other 
mechanical devices.  It is one of the pleasant surprises of science that silicon, which was 
intensively studied and developed for its electronic properties, also turns out to be an 
excellent mechanical material.5 
The field of microfluidics began to develop rapidly after the popularization of Angell’s gas 
chromatograph.  A number of analytical chemists, both in industry and in academia, 
enthusiastically pursued the vision of an integrated “lab on a chip”.  At Ciba Geigy, the 
chemist Andreas Manz hosted Jed Harrison on a sabbatical visit and together they 
developed a microfabricated capillary electrophoresis device.6  Michael Ramsey at Oak 
Ridge National labs independently developed similar microfabricated separations devices.7  
The work of these groups was commercially developed by a startup company called 
Caliper Technologies, which created products for electrophoresis of DNA, RNA and 
proteins.  Meanwhile, a team at Pharmacia in Uppsala, Sweden spun out a “biosensor” 
group in the form of Biacore which developed a surface plasmon sensor with microfluidic 
sample manipulation.8  This work led to the eponymous Biacore machine for measuring 
molecular affinities, which has become widely used in the pharmaceutical industry. Several 
other companies joined the effort and a thriving academic community has pursued a 
number of applications of microfluidics to analytical chemistry using related 
approaches.9,10 
Despite the commercial success of Biacore and Caliper, those microfluidic technologies 
could only perform specific tasks, were limited in flexibility and did not achieve the elusive 
dream of a “lab on a chip”.   A key reason for this was that they had not solved the general 
problem of how to achieve arbitrary manipulation of fluids on a chip.  Electrokinetic 
techniques such as used by Caliper are useful for simple manipulations, but do not 
generalize to complex networks because it is not practical to perfectly balance a large 
network of effectively linear resistors, and all of the fluidic junctions are susceptible to 
diffusional leakage and undesired flows due to temperature changes and imperfections in 
fabrication.  In principle, these difficulties can all be overcome by the use of mechanical 
valves, and indeed there were several examples of microfabricated mechanical valves in the 
literature dating from Angell’s chromatograph - but none of those valves could be 
fabricated in a fully integrated and scalable fashion.11–14   
   
	  
The difficulty and technical gap can be best understood through an analogy with 
electronics.  The development of discrete components such as vacuum tubes and transistors 
enabled the development of powerful and useful electronic devices, including the first 
electronic computers.  Electrical engineers realized that they could design circuits of 
arbitrary complexity – but that there was a limit to the complexity of circuits which could 
be built in practice, due to errors in assembly, cold solder joints, and component failures.  
They called this limit the “tyranny of numbers”, and it represented a similar limitation for 
circuit design as was faced by the microfluidics community.15 In electronics, this problem 
was solved by Jack Kilby and Robert Noyce with their invention of the integration circuit 
and large scale integration, which enabled batch fabrication of arbitrarily large numbers of 
components with a small number of lithographic, deposition and processing steps.  It is 
important to note that Noyce and Kilby did not invent the first transistor; rather, they 
invented a way to fabricate large numbers of transistors and other electrical components 
which in turn revolutionized the complexity of electronic circuits which could be 
practically fabricated.16   
The development of an equivalent large scale integration in microfluidics awaited the birth 
of a new revolution in microfabrication – the development of “soft lithography” by George 
Whitesides in the late 1990’s.17  Whitesides realized that the focus by MEMS and 
microfluidics researchers on hard materials such as silicon and glass was unnecessarily 
myopic.  In fact, the world of chemistry offered a much broader palette of materials to 
fabricate with which could unleash fantastic creativity.  The origin of Whitesides’s insight 
dates back to the 1940’s, when it was first realized that polymer materials could be used to 
mold replicas of very small sub-micron features.18  This observation was made in the 
context of electron microscopy, and the technique became widely used as a tool for 
enhancing contrast of three dimensional features for imaging. Whitesides adopted this 
replica molding approach for the purposes of chemical printing, by fabricating featured 
“stamps”,19 and then realized that it could be used much more generally for fabricating a 
wide variety of structures that were simply not accessible through planar silicon 
micromachining.  His group went on to fabricate a dizzying array of structures, including 
linked rings,20  three dimensional conducting coils,21 basket weave structures,22 blazed 
gratings,23 lasers,24 and optical wave guides.25  Soft lithography was eventually applied to 
make functional microfluidic structures, of which the earliest examples were for 
electrophoresis, molecular cytometry, and cell sorting.26–29 Soft lithography became widely 
adopted in the academic community and has become the de facto fabrication standard for 
many applications of microfluidics, especially in biology.30,31  It is difficult to overstate the 
impact this approach has had on the field of microfluidics due to its simplicity, flexibility, 
and rapid turnaround time – all of which empower researchers in ways that weren’t 
possible previously. 
Inspired by the power of soft lithography and the flexibility (both literally and 
metaphorically) of polydimethylsiloxane, the preferred material which Whitesides had also 
popularized, my group invented a monolithic integrated valve which could be batch 
fabricated.32   We realized that every macroscopic valve needs a flexible rubber valve seat 
to prevent leaking (usually supplied by a rubber washer) and we decided to fabricate the 
entire valve out of the flexible material PDMS.  By bonding together two layers of molded 
PDMS structures produced by soft lithography (so-called “Multilayer Soft Lithography”), 
we were able to fabricate pairs of perpendicular channels in separate layers, which were 
separated only by a thin PDMS membrane at the point at which they crossed each other.  
When we applied pneumatic pressure to one of the channels, the membrane deflected into 
   
	  
the other channel, thus blocking fluid flow.   Making a leak-proof valve required us to 
develop approaches which enabled careful control of the channel geometry of the mold, 
since rectangular cross-section channels would not seal perfectly due to the singularity 
required in membrane deflection.  Thus we adopted a process to create rounded channels 
on the mold structure and hence conformal deflection of the membrane would create a 
leak-proof seal.  Another technical innovation that was required was to understand and 
compensate for differential shrinkage of PDMS during the curing process, since the two 
layers had slightly different chemical composition and hence difference curing properties.  
Finally, we had to figure out how to bond two PDMS layers together, which we 
accomplished by using off-ratio mixing of the two components, creating an excess of 
monomer in one layer and an excess of catalyst in the other layer. 
The beauty of this approach is that fabrication is simple – two lithography steps to create to 
separate molds, followed by two PDMS molding steps, followed by a bonding step.  Since 
the features were determined by lithography, we could make as many valves as we wanted 
in a single device without increasing the fabrication complexity – we only had to design a 
more complicated mask on the computer.  We demonstrated this rather dramatically by 
fabricating devices with hundreds of valves in a single chip and showed that we could 
create microfluidic memory devices, as well as devices used for screening cellular 
reactions.  We termed this approach “Microfluidic Large Scale Integration”, in analogy 
with microelectronic LSI, and realized we had solved the outstanding problem that had 
prevented realization of the “Lab on a Chip” vision.  This breakthrough was published in 
2002,33 a mere two years after the first publication of our valve technology, and represented 
two orders of magnitude increase in complexity per chip.  These integrated valves have 
found many applications in biology, including protein crystallization for structural biology, 
measuring molecular affinities, digital PCR, and single cell genomics.  They have been 
commercially developed and are manufactured by Fluidigm, whose products are now used 
in thousands of labs around the world.  Fluidigm’s most complex chips contain tens of 
thousands of valves each, and cumulatively Fluidigm has manufactured and shipped 
billions of valves to customers.  Collectively, this shows that PDMS chips are 
manufacturable and that chips with high density valves have been successfully transitioned 
from academia to routine commercial use, thus completing the vision of microfluidic 
automation of biology as an analogue of electronic automation of computation some two 
decades after it was first articulated. 
It is natural to ask how to move beyond thousands of experiments on a chip to millions and 
larger.  Valve densities have improved according to a microfluidic “Moore’s law”,34 but in 
order to keep improving experimental density and throughput one will probably need to 
develop other technologies.  A promising candidate for this is microfluidic emulsions on a 
chip, or “droplet microfluidics”, first developed in my lab in 2001.35  We were inspired by 
a paper by Dan Tawfik and Andrew Griffiths, who showed that in certain special cases 
benchtop emulsions could be used to perform laboratory evolution of proteins.36  The 
emulsions were used to encapsulate separate reactions and measure the product from a 
given protein mutant.  Unfortunately, this approach placed severe restrictions on the type of 
assay one could use, and we realized that if we could create a microfluidic emulsion 
format, it would be possible to screen each droplet individually, thus vastly increasing the 
flexibility of the system and the types of proteins that could be evolved.  We designed chips 
that had junctions of two channels into a third output channel, and filled one of the inputs 
with water and the other with oil.  Much to our surprise, when we applied constant 
pressures on the inputs, an instability developed at the junction and small droplets of water 
   
	  
were periodically budding off into the flowing stream of oil, thus naturally creating 
emulsions in large amounts without the need for external manipulation on a per droplet 
basis. 
As we began to study the system, we realized that there was a rich variety of physical 
behaviors.  We could make polydisperse emulsions, ribbons of droplets with long range 
coherent order, trains of droplets and so forth.  We spent some effort trying to understand 
these and explain the basic physics of the system,35 and our first publication attracted 
interest in the fluid physics community.37  We made a variety of devices both to explore the 
basic droplet formation phenomena and also to turn it into a screening system for molecular 
evolution, including showing that we could sort droplets with integrated valves on the chip, 
that we could trap bacteria in the droplets, and that we could assay enzyme kinetics in the 
droplets.38  This idea of using droplets to screen experiments was enthusiastically accepted 
by the microfluidics community and a number of researchers jumped into the field, making 
rapid progress.39  Rustem Ismagilov showed that our work in protein crystallization could 
be transported to the droplets, that one could assay various enzyme kinetics in a rigorous 
fashion, and that one could study a variety of complex chemical phenomena.40  David 
Weitz developed a way to sort droplets at high speed using integrated electrodes and 
decided to complete the program of screening for molecular evolution of proteins, with 
dramatic success.41 BioRad offers a digital PCR system based on droplet microfluidics.  In 
addition to several companies now offering products based on this technology, there is a 
thriving academic community which continues to explore the basic science and 
technological applications of droplet microfluidics.  This approach enables very large 
numbers of experiments on a chip, but without the sophisticated fluid manipulation 
flexibility achieved with the valves, and is often a valuable complementary approach.   
The	  Science	  of	  Microfluidics	  
There is a rich and diverse physics to explore in trying to understand the behavior of fluids 
in small volumes (or at small length scales).  Often these phenomena are organized 
according to dimensionless numbers which estimate the relative magnitude of competing 
effects.  The most famous of these numbers is the Reynolds number, which was introduced 
to understand the transition from laminar flow to turbulence, and which estimates the ratio 
of inertial forces to viscous (ie friction) forces.  At small length scales, the Reynolds 
number is small, which means that flow is laminar and dominated by viscous friction.  This 
is not a small effect: the practical consequences of this on one’s ability to swim were 
famously discussed by Ed Purcell in his monograph “Life at Low Reynolds Number”.42  
There are many other physical effects that make the microfluidic world quite different from 
our experience with macroscopic fluids, and there has been a tremendous amount of 
research and cleverness devoted to understanding these effects and exploiting them to 
create microfluidic devices without a macroscale analogue, as described here.43  
Early critics of the field argued that microfluidics was “trivial” because low Reynolds 
number renders the differential equations describing fluid flow linear, resulting in “simple” 
Stokes flow.  However, the situation is actually much more subtle than that, and 
considering microfluidic problems has actually been quite fertile in terms of understanding 
basic fluid physics.  As a simple example, laminar flow presents a well controlled 
experimental environment to explore the behavior of complex fluids such as polymer 
solutions.  The dimensionless number associated with a polymer solution is the 
Weissenberg number, which is the product of the intrinsic relaxation time of the polymer 
with the shear rate of the fluid, and it is an estimate of the energy being put into stretching 
   
	  
the polymer.  It is often challenging to understand complex fluids at the macroscale 
because the non-linearities of inertial flow get convolved with the non-linearities of the 
polymer solution.   However, studying complex fluids in microscale devices leaves one 
with only the nonlinearity of interest to study, because one can simultaneously be at low 
Reynolds number and high Weissenberg number.  We used this insight to create devices 
which displayed a variety of interesting behaviors in the realm of “fluidic logic”, including 
a constant current source,44 a fluidic rectifier,45 and a fluidic flip-flop gate,44 all of which 
were specially designed channel geometries filled with a dilute polymer solution.  These 
devices provide a route to creating miniaturized fluidic logic circuits since macroscale 
fluidic logic depends on inertial effects which do not scale usefully. 
For many years the low Reynolds number environment was considered a major challenge 
for microfluidics: how could one achieve efficient mixing of fluids when transport is 
dominated by diffusion, which is generally a slow process? Many groups ultimately found 
clever solutions to problems, and one of the most powerful and useful ideas came from 
Whitesides, who showed that it was possible to create a “chaotic mixer” which used 
patterned surfaces to create circulating flows which cause an advecting fluid to fold over 
itself in a baker’s dough pattern.46  This reduces the length scales over which diffusion 
needs to act, and in turns greatly accelerates mixing in a fluid as it flows through the 
channel.  Many groups have made use of this component in their microfluidic devices.  
Whitesides also took advantage of the properties of low Reynolds number flow to design a 
microfluidic gradient generator, which allows one to create chemical gradients of arbitrary 
shape in a flowing fluid based on clever microfluidic channel design.47  They showed that it 
was possible to use this device to create gradients of a variety of shapes, and that such 
gradients could be used to study chemotaxis of cells.48 
Another example of how small volume fluid physics can be put to use is found in protein 
crystallization.  The most widely used technique to determine the structure of proteins is x-
ray crystallography, and this technique requires the protein to be grown in an atomically 
ordered crystal.  This can be challenging both because it is impossible to predict the correct 
protein crystallization conditions, necessitating many experiments, and because it is in 
general expensive and challenging to produce large amounts of a given protein.  Both of 
these challenges make protein crystallization a natural topic for microfluidic automation, 
and as my group began experimenting with microfluidic crystallization we noticed that we 
were having surprising success in our ability to grow crystals.49  As we started to think 
about what might be happening in our chip relative to bench top experiments, we realized 
that our crystallization experiments were operating in an interesting fluidic regime – that of 
low Grashof number. The Grashof number is defined as the ratio of buoyant forces to 
viscous forces, and therefore density driven convection is negligible when the Grashof 
number us small.  The particular geometry of the chambers in our experiment and the 
diffusion-driven mixing kinetics of protein and precipitant (in conjunction with the absence 
of convection) meant that our experiments were implementing a crystallization reaction 
known as free interface diffusion (FID).  FID represents a heuristically optimal traversal of 
phase space, in that proteins see a rapidly increasing precipitant concentration, which 
serves to nucleate crystals, followed by a decreasing protein concentration, which slows the 
growth kinetics to allow atomically ordered crystals to form.  This particular approach is in 
general challenging to implement, and was a motivation for NASA to perform microgravity 
crystallization experiments in space, but it becomes absolutely straightforward to do on 
earth in a microfluidic environment.  
   
	  
Microfluidics	  in	  Biology	  and	  Biochemistry	  
Microfluidic technologies have found applications in many fields – including medical 
diagnostics, ink jet printers, analytical chemistry, batteries and energy storage, and water 
filtration and purification.  In this section I will focus on some of the substantial and 
transformative applications in one of the most exciting and fast moving fields of science: 
biology.  Microfluidic devices provide a powerful approach for automation and have 
enabled experiments that would not otherwise be possible in areas as diverse as structural 
biology, biochemistry, biophysics, genetics, and cell biology.  This has been a focus of my 
own research and after having developed microfluidic large scale integration, we then set 
out to explore its applications to biology. 
One of the first areas we explored was structural biology, for the reasons outlined above.  
In collaboration with James Berger we developed a chip to do highly parallel FID 
crystallization experiments – 144 experiments with only a few microliters of protein 
solution.49 This chip was commercialized by Fluidigm and was used in structural biology 
labs around the world for nearly a decade.  Many of the structures were determined by 
pharmaceutical companies and kept proprietary, but a number of structures solved by 
academic groups were published in the scientific literature.50–61   Some of these structures 
were very important in human health, and include an Ebola virus glycoprotein bound to an 
antibody from a survivor,57  hemagglutinin from from H5N1 influenza virus,58  the LDL 
cholesterol receptor complexed with PCSK9,59 and integrins bound to fibrinogen-mimic 
therapeutics.60 Other chips we developed for the purpose of structural biology include a 
“formulator” which automates experiments to measure the phase behavior of proteins, thus 
enabling one to rationally design protein crystallization screens customized for the protein 
of interest.62  We also developed a chip which enables one to grow protein crystals in a 
microfluidic environment and then use the chip in a synchrotron beam line to take 
diffraction data in situ.63  Both of these approaches were able to substantially increase 
success rates in crystallization and quality of diffraction data.64 
We became interested in using microfluidics to measure molecular interactions, which led 
us to develop a technology called Mechanically Induced Trapping of Molecular 
Interactions (MITOMI). 65  The principle of this approach is to use a deflectable membrane 
– very similar to the valve – which can trap molecular interactions on a glass surface. For 
example, if a transcription factor is anchored to the surface under the membrane, when the 
membrane is open and fluorescently labeled DNA is in solution, an equilibrium of bound 
and unbound DNA is reached.  When the membrane is lowered, it traps the bound DNA 
against the surface and the unbound DNA can be washed away.  If the remaining DNA 
happens to dissociate from the transcription factor, it will be retained against the surface by 
the membrane.  In this fashion the off rate kinetics of the interaction are decoupled from the 
measurement, and it is possible to quantitate the bound DNA at one’s leisure.  We initially 
built a chip with 400 such measurement units, and later built a chip with 4,000 unit cells.66  
A first application of the MITOMI chip was to measure the free energy of binding of a 
transcription factor against all possible DNA sequences, from which we were able to show 
that it was sufficient to use a table of such energies along with informatics knowledge of 
the genome to correctly predict which genes were regulated by the transcription factor.  We 
also were able to show that linear approaches to represent sequence motifs do not capture 
the full complexity of the sequence recognition properties of a transcription factor.67   In 
later work, we went on to use the MITOMI chip for drug screening68 and to measure 
   
	  
protein-protein interactions.69  The latter ability enabled us to perform a proteome-wide 
screen in staph aureus in order to discover putative function of unannotated genes.70  
Microfluidics have also become a powerful tool to automate genetic analysis.  As one 
example, digital PCR is a technique which in principle allows absolute quantitation of 
nucleic acids.71  This method uses limiting dilution to make aliquots which contain on 
average less than one DNA molecule.  By performing PCR on all of the aliquots and 
measuring which aliquots have product, one can calculate how many starting molecules 
were in the initial solution in such a way that the quantitation is completely decoupled from 
amplification efficiency.  This solves an outstanding problem in nucleic acid measurement 
and corrects one of the drawbacks of conventional PCR, but was impractical to perform 
with conventional fluid manipulations.  It was evident the microfluidics could solve this 
problem, and Fluidigm used microfluidic large scale integration to develop the first 
commercial digital PCR system, for which applications were developed by many groups 
around the world.  There are applications in basic science, such as single cell gene 
expression72,73, discovering gene-organism relationships in the termite gut microbiome74  
and discovery of virus-host relationships.75  Digital PCR can be used for measurements in 
clinical genetics76, cancer diagnostics,77,78 as well as for measuring GMO contamination in 
food.79,80  Eventually droplet microfluidics was used to develop second generation digital 
PCR products, now sold by Biorad, which have increased the throughput and scaling of 
such measurements. 
Another example of microfluidic automation in genetic analysis is the development of PCR 
arrays. 81 We used microfluidic large scale integration to develop a reactor matrix, in which 
there are channels which form columns and rows, and a reactor exists at every vertex.  This 
approach enables one to perform N2 experiments with only 2N pipetting steps, and it solves 
the “world to chip” problem by using each pipetted reagent for at least N reactions.  This 
idea was commercially developed by Fluidigm and their Dynamic Array now has a 96x96 
matrix, enabling more than 9,000 experiments to be performed with less than 200 pipetting 
steps.  Typically DNA templates are loaded in one axis and PCR primers are loaded on the 
other axis, and the machine performs real time quantitative PCR, enabling measurement of 
either gene expression or genotyping.  This device has found many applications, ranging 
from managing salmon fisheries in Alaska82 to single cell gene expression analysis.83,84  
Single cell genomics is an application of microfluidics in biology which is currently 
receiving intense attention.  This area has moved beyond the single cell PCR measurements 
described above to whole genome and transcriptome sequencing from single cells.  We 
used microfluidic large scale integration to sequence the first single cell genome from an 
uncultivated environmental microbe,85 and have continued to use this approach to analyze a 
number of uncultivated microbial genomes.86–90  As sequencing costs decreased, we 
developed devices which enabled single cell human genome analysis, which we used to 
perform human genome haplotyping91 as well as an analysis of recombination statistics and 
de novo mutations in human sperm cells.92  Fluidigm developed a commercial product 
called the C1 based on our work, and this device is now used in laboratories around the 
world to perform single cell transcriptome and genome sequencing.  In my group, among 
other applications, we have used this device to study the developing mouse lung,93  adult 
human neurons,94 cellular reprogramming,95 and the clonal structure of cancer.96  The 
flexibility of microfluidic large scale integration has enabled this system to be used for 
other single cell measurements, such as epigenetic analysis by ATAC-seq.  David Weitz 
and collaborators used droplet microfluidics to develop a device for single cell 
   
	  
transcriptome analysis97,98 which can do larger numbers of cells but at lower transcriptome 
coverage, which has now reached the commercial market through the company 10x 
Genomics and which is enjoying a number of clever applications.99,100   
Conclusion	  
Microfluidics as a field has matured enormously since its founding nearly four decades 
ago.  Early dreams of creating the biological equivalent of the integrated circuit have been 
realized through the development of microfluidic large scale integration, enabling one to 
fabricate a “lab on a chip” with tens of thousands of individual micromechanical valves, 
and similarly to fabricate chips which make millions of individual encapsulated droplet 
experiments.  None of this would have been possible without the development of a 
revolutionary new fabrication technology known as soft lithography, which introduced new 
processes and materials. Microfluidic technologies have moved beyond academic 
laboratories and there is now a thriving industry for devices based around biological and 
biochemical measurement, with many companies in the space and aggregate sales of 
hundreds of millions of dollars per year.  These tools have truly solved the “tyranny of 
pipetting” problem and have powered discoveries in numerous areas of biology. 
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